A Phase I Multiple-Dose Study Evaluating the Pharmacokinetics (PK) and Safety of Brexpiprazole in Japanese Patients with Schizophrenia

Trial Profile

A Phase I Multiple-Dose Study Evaluating the Pharmacokinetics (PK) and Safety of Brexpiprazole in Japanese Patients with Schizophrenia

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Aug 2017

At a glance

  • Drugs Brexpiprazole (Primary)
  • Indications Schizophrenia
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 02 Aug 2017 New trial record
    • 27 Jul 2017 Results published in the Journal of Clinical Pharmacology Journal.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top